{
    "title": "Individual feed for https://www.marketbeat.com/feed/",
    "link": "https://www.marketbeat.com/feed/",
    "description": "Individual feed output.",
    "lastBuildDate": "2025-11-19T22:12:58.265448",
    "items": [
        {
            "title": "onsemi Places a $6 Billion Bet on Its Own Stock",
            "link": "https://www.marketbeat.com/originals/onsemi-places-a-6-billion-bet-on-its-own-stock/",
            "description": "onsemi's new multi-billion-dollar share repurchase program signals strong management confidence in its future growth and commitment to shareholder val...",
            "pubDate": "2025-11-19T17:22:00",
            "image_url": "https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture1.png"
        },
        {
            "title": "HIMS Has Been a Roller Coaster Ride. Should Investors Hop On?",
            "link": "https://www.marketbeat.com/originals/hims-has-been-a-roller-coaster-ride-should-investors-hop-on/",
            "description": "Hims & Hers Health may only generate a fraction of its competitors revenue, but its fiscal management and exponential growth point to a very bright fu...",
            "pubDate": "2025-11-19T16:27:00",
            "image_url": "https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture10.png"
        },
        {
            "title": "End the Year Strong With These 3 Comeback Champions",
            "link": "https://www.marketbeat.com/stock-ideas/end-the-year-strong-with-these-3-comeback-champions/",
            "description": "Delta Air Lines, Diamondback Energy, and HEICO could all benefit from internal and external drivers of momentum heading into the end of the year.",
            "pubDate": "2025-11-19T15:08:00",
            "image_url": "https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture6.png"
        },
        {
            "title": "Down 45% Year-to-Date, Novo Nordisk Ignites a Price War",
            "link": "https://www.marketbeat.com/originals/down-45-year-to-date-novo-nordisk-ignites-a-price-war/",
            "description": "Novo Nordisk's new pricing for its GLP-1 drugs is a strategic pivot to capture a mass market, pressure rivals, and secure long-term market dominance.",
            "pubDate": "2025-11-19T12:04:00",
            "image_url": "https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture4.png"
        },
        {
            "title": "Institutions Love These 3 Companies, Should You As Well?",
            "link": "https://www.marketbeat.com/originals/institutions-love-these-3-companies-should-you-as-well/",
            "description": "Retail investors seeking companies vetted by professionals might look to these three companies, all of which are heavily owned by institutional invest...",
            "pubDate": "2025-11-19T11:45:00",
            "image_url": "https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture8.png"
        }
    ]
}